Study Evaluating the Etiology of Intra-Abdominal Infections
NCT00244088 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 340
Last updated 2009-09-01
Summary
The aim of this study is to define the etiology of intra-abdominal infections, to study the role of Enterococcus spp and Pseudomonas aeruginosa in these infections and to clarify the need for specific enterococcal antimicrobial coverage.
Conditions
- Intra-abdominal Infection
Sponsors & Collaborators
-
Wyeth is now a wholly owned subsidiary of Pfizer
lead INDUSTRY
Principal Investigators
-
Medical Monitor · Wyeth is now a wholly owned subsidiary of Pfizer
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2004-04-30
- Primary Completion
- 2004-12-31
- Completion
- 2004-12-31
More Related Trials
-
Intensive Care Unit Acquired Infections in Patients Colonized With Extended Spectrum Enterobacteriaceae
NCT04903886 ·Status: UNKNOWN
-
A Comparative Study of Ampicillin/Sulbactam Versus Moxifloxacin in the Treatment of Complicated Intra-abdominal Infections
NCT00952796 ·Status: COMPLETED ·Phase: PHASE4
-
Study Comparing Tigecycline Versus Ceftriaxone Sodium Plus Metronidazole in Complicated Intra-abdominal Infection (cIAI)
NCT00230971 ·Status: COMPLETED ·Phase: PHASE4
-
A Study To Determine The Efficacy And Safety Of Tigecycline Compared With Imipenem/Cliastatin to Treat Complicated Intra-Abdominal Infection
NCT01721408 ·Status: COMPLETED ·Phase: PHASE4
-
Pilot Trial of Antibiotics Versus Surgery for Treating Acute Appendicitis
NCT02447224 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
A Study to Evaluate the Safety and Effectiveness of Ertapenem Versus Ceftriaxone/Metronidazole in the Treatment of Intra-abdominal Infections in Adults (0826-802)
NCT00481702 ·Status: COMPLETED ·Phase: PHASE3
-
Reporting Patterns and Results of Initial Antibiotic Treatment in Patients With cUTI, cIAI,NP Including VAP
NCT02364284 ·Status: COMPLETED
-
GSK2251052 in the Treatment of Complicated Intra-abdominal Infections
NCT01381562 ·Status: TERMINATED ·Phase: PHASE2
-
Moxifloxacin Versus Ceftriaxone in the Treatment of Primary Pyogenic Liver Abscess
NCT00895089 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Evaluate Ertapenem Versus It's Comparator in the Treatment of Complicated Intra-abdominal Infections in Adults (0826-050)(COMPLETED)
NCT00157898 ·Status: COMPLETED ·Phase: PHASE4
-
Compare Ceftazidime-Avibactam + Metronidazole vs Meropenem for Hospitalized Adults With Complicated Intra-Abd Infections
NCT01726023 ·Status: COMPLETED ·Phase: PHASE3
-
A Randomized Controlled Pilot Trial of Indomethacin in Acute Pancreatitis
NCT02692391 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety Study of Eravacycline Compared With Ertapenem in Complicated Intra-abdominal Infections
NCT01844856 ·Status: COMPLETED ·Phase: PHASE3
-
Moxifloxacin i.v. in the Treatment of Complicated Intra-Abdominal Infection (cIAI)
NCT01096511 ·Status: COMPLETED
-
Study Comparing Tigecycline Versus Ceftriaxone Sodium Plus Metronidazole in Complicated Intra-abdominal Infection
NCT00195351 ·Status: COMPLETED ·Phase: PHASE4
-
Study Comparing the Safety and Efficacy of Intravenous CXA-201 and Intravenous Levofloxacin in Complicated Urinary Tract Infection, Including Pyelonephritis
NCT01345929 ·Status: COMPLETED ·Phase: PHASE3
-
Importance of Peritoneal Free Fluid Cultures in Acute Appendicitis
NCT01953289 ·Status: WITHDRAWN
-
Impact of Specific Antimicrobials and MIC Values on the Outcome of Bloodstream Infections Due to Extended-spectrum Beta-lactamase (ESBL) or Carbapenemase-producing Enterobacteriaceae: an Observational Multinational Study
NCT01764490 ·Status: COMPLETED
-
Dragon Study (the Safety and Efficacy for Treatment of Patients With Complicated Intra Abdominal Infections)
NCT00769171 ·Status: COMPLETED ·Phase: PHASE3
-
Therapy of Complicated Intra-Abdominal Infections With Moxifloxacin or Ertapenem
NCT00492726 ·Status: COMPLETED ·Phase: PHASE3
-
Compare Ceftazidime-Avibactam + Metronidazole Versus Meropenem for Hospitalized Adults With Complicated Intra-Abdominal Infections
NCT01499290 ·Status: COMPLETED ·Phase: PHASE3
-
Clinical Significance and Optimal Treatment of Community-onset Urinary Tract Infections Caused by Extended-spectrum β-lactamase and/or AmpC β-lactamase Producing Enterobacteriaceae
NCT01138566 ·Status: UNKNOWN
-
Study of Antibiotic Utilization Measures and Control of ESBLs in China
NCT00488813 ·Status: COMPLETED ·Phase: PHASE4
-
Developing Microbials to Fight Extended-spectrum Beta-lactamase (ESBL)-Producing Escherichia Coli
NCT04764500 ·Status: ACTIVE_NOT_RECRUITING
-
SIS Multicenter Study of Duration of Antibiotics for Intraabdominal Infection
NCT00657566 ·Status: COMPLETED ·Phase: PHASE3